HealthEquity announces fiscal 2027 revenue outlook of $1.38-$1.41 billion and reaffirm availability of 2026 guidance.
Quiver AI Summary
HealthEquity, Inc. announced its fiscal outlook for the year ending January 31, 2027, estimating revenues between $1.38 billion and $1.41 billion, with an Adjusted EBITDA margin of 43.8% to 44.3% and a yield on HSA Cash around 3.75%. The company reaffirmed its guidance for the fiscal year ending January 31, 2026. CEO Scott Cutler highlighted the company’s progress in modernizing the business, enhancing security, and improving digital engagement, positioning HealthEquity for durable growth amidst ongoing challenges in healthcare affordability. The company has over 17 million accounts and collaborates with a wide range of partners. They will present further details at the J.P. Morgan Healthcare Conference on January 13, 2026.
Potential Positives
- HealthEquity projects robust revenue growth for fiscal year 2027, expecting revenues between $1.38 billion and $1.41 billion, indicating strong business momentum.
- The company is reaffirming its guidance for fiscal year 2026, demonstrating confidence in its financial performance and stability.
- HealthEquity emphasizes its position as the largest HSA custodian in the nation, underscoring its leadership in the growing health savings market.
- The company highlights a focus on modernizing its business and enhancing security, which could lead to increased trust and engagement from consumers and partners.
Potential Negatives
- Management provided a revenue outlook for fiscal year 2027 that reflects only modest growth compared to prior expectations, which could indicate slower than anticipated business momentum.
- The company did not include a reconciliation of Adjusted EBITDA to net income, citing difficulties in predicting significant items like stock-based compensation, which may raise concerns about financial transparency.
- There are numerous forward-looking statements in the release that include extensive risks, uncertainties, and assumptions, suggesting that the company acknowledges significant challenges that could impact their future performance.
FAQ
What is HealthEquity's revenue outlook for fiscal year 2027?
HealthEquity expects revenues between $1.38 billion and $1.41 billion for the fiscal year ending January 31, 2027.
Who is the CEO of HealthEquity?
Scott Cutler serves as the President and CEO of HealthEquity.
When will HealthEquity present at the J.P. Morgan Healthcare Conference?
HealthEquity will present on January 13, 2026, at 3:00 PM Pacific Time.
What are HSAs and their importance to HealthEquity?
HealthEquity specializes in health savings accounts (HSAs) which are vital for financing healthcare for Americans.
How many accounts does HealthEquity manage?
HealthEquity manages more than 17 million accounts in partnership with various organizations.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HQY Insider Trading Activity
$HQY insiders have traded $HQY stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $HQY stock by insiders over the last 6 months:
- ELIMELECH ROSNER (EVP, CHIEF TECHNOLOGY OFFICER) sold 10,959 shares for an estimated $1,046,090
- DELANO LADD (EVP, General Counsel) has made 0 purchases and 6 sales selling 10,500 shares for an estimated $1,001,672.
- GAYLE FURGURSON WELLBORN sold 4,339 shares for an estimated $425,330
- EVELYN S DILSAVER sold 3,461 shares for an estimated $322,915
- MICHAEL HENRY FIORE (EVP, CHIEF COMMERCIAL OFFICER) sold 1,781 shares for an estimated $157,102
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HQY Revenue
$HQY had revenues of $322.2M in Q3 2026. This is an increase of 7.23% from the same period in the prior year.
You can track HQY financials on Quiver Quantitative's HQY stock page.
$HQY Hedge Fund Activity
We have seen 243 institutional investors add shares of $HQY stock to their portfolio, and 245 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,550,235 shares (-30.8%) from their portfolio in Q3 2025, for an estimated $146,915,770
- CIBC PRIVATE WEALTH GROUP LLC removed 913,648 shares (-81.1%) from their portfolio in Q3 2025, for an estimated $86,586,420
- PRICE T ROWE ASSOCIATES INC /MD/ added 833,361 shares (+119.0%) to their portfolio in Q3 2025, for an estimated $78,977,621
- CITADEL ADVISORS LLC removed 783,572 shares (-64.7%) from their portfolio in Q3 2025, for an estimated $74,259,118
- AQR CAPITAL MANAGEMENT LLC added 656,820 shares (+59.3%) to their portfolio in Q3 2025, for an estimated $62,246,831
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 590,267 shares (-98.1%) from their portfolio in Q3 2025, for an estimated $55,939,603
- POINT72 ASSET MANAGEMENT, L.P. added 561,025 shares (+inf%) to their portfolio in Q3 2025, for an estimated $53,168,339
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HQY Analyst Ratings
Wall Street analysts have issued reports on $HQY in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 12/04/2025
- BTIG issued a "Buy" rating on 12/04/2025
- Keybanc issued a "Overweight" rating on 10/08/2025
- Jefferies issued a "Buy" rating on 09/03/2025
- JP Morgan issued a "Overweight" rating on 09/03/2025
- Barrington Research issued a "Outperform" rating on 09/03/2025
- RBC Capital issued a "Outperform" rating on 08/28/2025
To track analyst ratings and price targets for $HQY, check out Quiver Quantitative's $HQY forecast page.
$HQY Price Targets
Multiple analysts have issued price targets for $HQY recently. We have seen 11 analysts offer price targets for $HQY in the last 6 months, with a median target of $125.0.
Here are some recent targets:
- David Roman from Goldman Sachs set a target price of $89.0 on 01/09/2026
- Scott Schoenhaus from Keybanc set a target price of $125.0 on 01/08/2026
- Glen Santangelo from Barclays set a target price of $118.0 on 12/09/2025
- Constantine Davides from Citizens set a target price of $122.0 on 12/04/2025
- David Larsen from BTIG set a target price of $130.0 on 12/04/2025
- Alexander Paris from Barrington Research set a target price of $125.0 on 12/04/2025
- Alexei Gogolev from JP Morgan set a target price of $129.0 on 12/04/2025
Full Release
DRAPER, Utah, Jan. 12, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian by number of accounts and leading provider of complimentary consumer-directed benefits (“CDBs”), today announced its initial outlook for its fiscal year ending January 31, 2027 and reaffirmed previously provided guidance for its fiscal year ending January 31, 2026.
For the fiscal year ending January 31, 2027, management expects revenues in the range of $1.38 billion to $1.41 billion with Adjusted EBITDA margin of 43.8% to 44.3% and a yield on HSA Cash of approximately 3.75%.
“Today, we issued our initial fiscal 2027 outlook, reflecting the progress we’ve made strengthening HealthEquity’s foundation and building momentum as a scaled platform," said Scott Cutler, President and CEO of HealthEquity. "Over the past year, we’ve modernized the business, raising the bar on security and trust, accelerating the digital experience, and driving engagement, so the model compounds over time. Healthcare affordability is a structural challenge, making HSAs increasingly central to how Americans finance care. With our scale and an ecosystem of 200+ integrated Network Partners, including health and retirement plan partners, brokers and benefit advisors, we believe HealthEquity is positioned to drive durable growth and create long-term value for shareholders."
HealthEquity will discuss these estimates and expectations for its fiscal 2027 during a presentation by Scott Cutler, President and CEO, Steve Neeleman, Vice Chair and Founder and James Lucania, EVP and CFO, at the 44 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 3:00 pm Pacific Time in the Union Square Room of the St. Francis Hotel.
An audio webcast of the presentation along with a copy of the presentation slides will be available and archived on HealthEquity’s investor relations website at http://ir.healthequity.com .
About HealthEquity
HealthEquity and its subsidiaries provide HSAs and other consumer-directed benefits for more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to save and improve lives by empowering healthcare consumers. For more information, visit www.healthequity.com .
Non-GAAP financial information
A reconciliation of our Adjusted EBITDA outlook for the fiscal year ending January 31, 2027 to net income, its most directly comparable GAAP measure, is not included, because our net income outlook for this future period is not available without unreasonable efforts as we are unable to predict certain significant items excluded from this non-GAAP measure, such as stock-based compensation expense and income tax provision.
Forward-looking statements
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our New HSAs from Sales, HSA Assets, Total Accounts, industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, acquisition synergies, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “aims,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.
Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:
- our ability to adequately place and safeguard our custodial assets, or the failure of any of our depository or insurance company partners;
- our ability to compete effectively in a rapidly evolving healthcare and benefits administration industry;
- our dependence on the continued availability and benefits of tax-advantaged HSAs and other CDBs;
- the impact of fraudulent account activity involving our member accounts or our third-party service providers on our reputation and financial results;
- our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
- the significant competition we face and may face in the future, including from those with greater resources than us;
- our reliance on the availability and performance of our technology and communications systems;
- potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
- the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
- our ability to comply with current and future privacy, healthcare, tax, ERISA, investment adviser and other laws applicable to our business;
- our reliance on partners and third-party vendors for distribution and important services;
- our ability to develop and implement updated features for our technology platforms and communications systems; and
-
our reliance on our management team and key team members.
For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the fiscal year ended January 31, 2025, and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.
Investor Relations Contact:
Richard Putnam
801-727-1000
[email protected]